Vivoryon Therapeutics N.V. buy melinda
Start price
27.11.21
/
50%
€18.36
Target price
27.11.22
€19.00
Performance (%)
-50.44%
End price
28.11.22
€9.10
Summary
This prediction ended on 28.11.22 with a price of €9.10. Massive losses of -50.44% were the result for the BUY prediction by melinda. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Vivoryon Therapeutics N.V. | -6.413% | -6.413% | -96.770% |
| iShares Core DAX® | -0.870% | -1.700% | 10.560% |
| iShares Nasdaq 100 | -5.561% | -3.604% | 34.335% |
| iShares Nikkei 225® | -6.138% | -7.732% | 16.215% |
| iShares S&P 500 | -3.141% | -2.011% | 24.534% |
According to melinda what are the pros and cons of Vivoryon Therapeutics N.V. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by melinda for this prediction
In the thread Vivoryon Therapeutics AG diskutieren
Kursziel geändert auf 19,0
In the thread Trading Vivoryon Therapeutics AG
Die von melinda gewählte maximale Laufzeit wurde überschritten
Stopped prediction by melinda for Vivoryon Therapeutics N.V.
Vivoryon Therapeutics N.V.
Start price
Target price
Perf. (%)
€3.80
16.03.20
16.03.20
€5.00
04.11.21
04.11.21
437.55%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Vivoryon Therapeutics N.V.
Start price
Target price
Perf. (%)
€5.48
26.02.20
26.02.20
€7.50
16.03.20
16.03.20
-30.75%
16.03.20
16.03.20
Could be worthwhile Investment >10% per year
Vivoryon Therapeutics N.V.
Start price
Target price
Perf. (%)
€11.80
26.11.17
26.11.17
€17.00
16.01.18
16.01.18
23.74%
16.01.18
16.01.18
Could be worthwhile Investment >10% per year
Vivoryon Therapeutics N.V.
Start price
Target price
Perf. (%)
€11.80
26.11.17
26.11.17
€17.00
16.01.18
16.01.18
23.74%
16.01.18
16.01.18
Could be worthwhile Investment >10% per year